Jury Selection Scheduled for Murder Case in Manhattan
A judge has announced that jury selection for the federal murder case involving Luigi Mangione will commence in September. This comes as Mangione, 27, appears in court to challenge the prosecution’s attempt to seek the death penalty.
Dressed in tan prison attire and with his legs shackled, Mangione sat quietly at the defense table while Judge Margaret Garnett set a tentative date of September 8 for jury deliberations. This jury will ultimately decide his fate concerning the alleged assassination of UnitedHealthcare CEO Brian Thompson in 2024.
Before the jury selection can proceed, the judge will weigh Mangione’s bid to avoid the death penalty.
Mangione’s attorneys argue that federal officials have swayed potential jurors by presenting him in a way reminiscent of a comic book villain. They cited an incident where he was paraded in front of cameras during a “perp walk” alongside then-Mayor Eric Adams.
If the death penalty is dismissed, Garnett indicated that the trial could start as soon as October 12 of this year.
However, she noted that if the charges remain death penalty-eligible, jurors may be required to return for the trial, potentially rescheduled for January 2027.
Garnett set the jury selection date after Assistant U.S. Attorney Dominick Gentile argued for nearly three hours about the legality surrounding the case, specifically regarding the implications of the firearms-wrap murder which enables the government to pursue the death penalty.
The judge plans to provide a written decision later.
Even if the death penalty is not an option, Mangione could still face life imprisonment. This would be a significant setback for U.S. Attorney Pam Bondi, who aims for the first federal death sentence in Manhattan in over 70 years.
Supporters of Mangione, who seem to view him as a controversial folk hero despite the murder allegations, were present outside the courthouse during Friday’s proceedings. One supporter, Tatiana Slava, 35, an unemployed resident from New Jersey, expressed her understanding of Mangione’s actions, saying, “I don’t condone murder, but I understand why he committed it. We believe this will raise awareness of the injustices in the health care system.”
Another courtroom regular, Jonathan Gartreol, criticized the media portrayal of Mangione’s supporters, claiming they were unfairly labeled as a “fandom.” He argued that this trivializes their serious concerns, stating, “This is about real issues facing Americans. Calling us a ‘fandom’ is trying to downplay and diminish the importance of staying here, and we’re not going to allow that.”
Mangione faces accusations of killing Thompson on December 4, 2024, outside a health insurance company investor meeting in Midtown.
Prosecutors say that Mangione expressed intentions of targeting medical directors in his diary to highlight what he views as a predatory private health care system.
It remains unclear how the possibility of a federal trial starting as early as October will impact a separate state lawsuit filed by Manhattan District Attorney Alvin Bragg’s office.
Judge Gregory Caro has stated he will make a ruling by May 18 regarding Mangione’s efforts to suppress critical evidence, which includes the alleged murder weapon and his statements to police and prison guards.
Yet, Caro did not set a trial date following a lengthy three-week evidentiary hearing that concluded in December.
Mangione’s legal team is advocating for the federal case to proceed first, citing the significant implications involved. In a notebook, he allegedly wrote, “I apologize for the trauma-induced conflict, but it needed to happen. Frankly, the parasites were expecting it.”
